|
|
| (One intermediate revision by the same user not shown) |
| Line 1: |
Line 1: |
| == Exposure Estimated Risk ==
| | #REDIRECT[[HIV post-exposure prophylaxis]] |
| | |
| {| style="width: 500px" border="1" cellpadding="1" cellspacing="1"
| |
| |-
| |
| | '''Exposure^'''<br/>
| |
| | '''Risk'''<br/>
| |
| |-
| |
| | Percutaneous
| |
| | 0.3%
| |
| |-
| |
| | Mucocutaneous
| |
| | 0.09%
| |
| |-
| |
| | Needle-sharing injection drug
| |
| | 0.7%
| |
| |-
| |
| | Receptive anal intercourse
| |
| | 0.5%
| |
| |-
| |
| | Receptive penile-vaginal intercourse
| |
| | 0.1%
| |
| |-
| |
| | Insertive anal intercourse
| |
| | 0.07%
| |
| |-
| |
| | Insertive penile-vaginal intercourse
| |
| | 0.05%
| |
| |-
| |
| | Receptive oral (male) intercourse
| |
| | 0.01%
| |
| |-
| |
| | Insertive oral (male) intercourse
| |
| | 0.005%
| |
| |}
| |
| | |
| ^assumes no condom use
| |
| | |
| == Source ==
| |
| 8/07 DONALDSON
| |
| | |
| [[Category:ID]] | |
